Cargando…
An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer
The histone methyltransferase EZH2 has been studied most extensively in the context of PRC2-dependent gene repression. Accumulating evidence indicates non-canonical functions for EZH2 in cancer contexts including promoting paradoxical gene expression through interactions with transcription factors,...
Autores principales: | Dardis, Gabrielle J., Wang, Jun, Simon, Jeremy M., Wang, Gang Greg, Baldwin, Albert S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319845/ https://www.ncbi.nlm.nih.gov/pubmed/37416481 http://dx.doi.org/10.1016/j.isci.2023.107115 |
Ejemplares similares
-
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer
por: Aspros, Kirsten G. M., et al.
Publicado: (2022) -
The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)
por: SINKOVICS, JOSEPH G.
Publicado: (2015) -
The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)
por: Sinkovics, Joseph G.
Publicado: (2016) -
Addressing Reported Pro-Apoptotic Functions of NF-κB: Targeted Inhibition of Canonical NF-κB Enhances the Apoptotic Effects of Doxorubicin
por: Bednarski, Brian K., et al.
Publicado: (2009) -
C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymoma
por: Parker, Matthew, et al.
Publicado: (2014)